793 related articles for article (PubMed ID: 30455077)
21. Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.
Tongyoo S; Permpikul C; Mongkolpun W; Vattanavanit V; Udompanturak S; Kocak M; Meduri GU
Crit Care; 2016 Oct; 20(1):329. PubMed ID: 27741949
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the efficacy and safety of FP-1201-lyo (intravenously administered recombinant human interferon beta-1a) and placebo in the treatment of patients with moderate or severe acute respiratory distress syndrome: study protocol for a randomized controlled trial.
Bellingan G; Brealey D; Mancebo J; Mercat A; Patroniti N; Pettilä V; Quintel M; Vincent JL; Maksimow M; Jalkanen M; Piippo I; Ranieri VM
Trials; 2017 Nov; 18(1):536. PubMed ID: 29132404
[TBL] [Abstract][Full Text] [Related]
23. Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke (MASTERS): a randomised, double-blind, placebo-controlled, phase 2 trial.
Hess DC; Wechsler LR; Clark WM; Savitz SI; Ford GA; Chiu D; Yavagal DR; Uchino K; Liebeskind DS; Auchus AP; Sen S; Sila CA; Vest JD; Mays RW
Lancet Neurol; 2017 May; 16(5):360-368. PubMed ID: 28320635
[TBL] [Abstract][Full Text] [Related]
24. Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy]).
Bartolucci J; Verdugo FJ; González PL; Larrea RE; Abarzua E; Goset C; Rojo P; Palma I; Lamich R; Pedreros PA; Valdivia G; Lopez VM; Nazzal C; Alcayaga-Miranda F; Cuenca J; Brobeck MJ; Patel AN; Figueroa FE; Khoury M
Circ Res; 2017 Oct; 121(10):1192-1204. PubMed ID: 28974553
[TBL] [Abstract][Full Text] [Related]
25. The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study.
Bellingan G; Maksimow M; Howell DC; Stotz M; Beale R; Beatty M; Walsh T; Binning A; Davidson A; Kuper M; Shah S; Cooper J; Waris M; Yegutkin GG; Jalkanen J; Salmi M; Piippo I; Jalkanen M; Montgomery H; Jalkanen S
Lancet Respir Med; 2014 Feb; 2(2):98-107. PubMed ID: 24503265
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial.
Reck M; Kaiser R; Mellemgaard A; Douillard JY; Orlov S; Krzakowski M; von Pawel J; Gottfried M; Bondarenko I; Liao M; Gann CN; Barrueco J; Gaschler-Markefski B; Novello S;
Lancet Oncol; 2014 Feb; 15(2):143-55. PubMed ID: 24411639
[TBL] [Abstract][Full Text] [Related]
27. Higher vs lower positive end-expiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis.
Briel M; Meade M; Mercat A; Brower RG; Talmor D; Walter SD; Slutsky AS; Pullenayegum E; Zhou Q; Cook D; Brochard L; Richard JC; Lamontagne F; Bhatnagar N; Stewart TE; Guyatt G
JAMA; 2010 Mar; 303(9):865-73. PubMed ID: 20197533
[TBL] [Abstract][Full Text] [Related]
28. Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial.
Gorman E; Shankar-Hari M; Hopkins P; Tunnicliffe WS; Perkins GD; Silversides J; McGuigan P; Jackson C; Boyle R; McFerran J; McDowell C; Campbell C; McFarland M; Smythe J; Thompson J; Williams B; Curley G; Laffey JG; Clarke M; McAuley DF; O'Kane C
Trials; 2022 May; 23(1):401. PubMed ID: 35562778
[TBL] [Abstract][Full Text] [Related]
29. Effect of Lung Recruitment and Titrated Positive End-Expiratory Pressure (PEEP) vs Low PEEP on Mortality in Patients With Acute Respiratory Distress Syndrome: A Randomized Clinical Trial.
; Cavalcanti AB; Suzumura ÉA; Laranjeira LN; Paisani DM; Damiani LP; Guimarães HP; Romano ER; Regenga MM; Taniguchi LNT; Teixeira C; Pinheiro de Oliveira R; Machado FR; Diaz-Quijano FA; Filho MSA; Maia IS; Caser EB; Filho WO; Borges MC; Martins PA; Matsui M; Ospina-Tascón GA; Giancursi TS; Giraldo-Ramirez ND; Vieira SRR; Assef MDGPL; Hasan MS; Szczeklik W; Rios F; Amato MBP; Berwanger O; Ribeiro de Carvalho CR
JAMA; 2017 Oct; 318(14):1335-1345. PubMed ID: 28973363
[TBL] [Abstract][Full Text] [Related]
30. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial.
Röllig C; Serve H; Hüttmann A; Noppeney R; Müller-Tidow C; Krug U; Baldus CD; Brandts CH; Kunzmann V; Einsele H; Krämer A; Schäfer-Eckart K; Neubauer A; Burchert A; Giagounidis A; Krause SW; Mackensen A; Aulitzky W; Herbst R; Hänel M; Kiani A; Frickhofen N; Kullmer J; Kaiser U; Link H; Geer T; Reichle A; Junghanß C; Repp R; Heits F; Dürk H; Hase J; Klut IM; Illmer T; Bornhäuser M; Schaich M; Parmentier S; Görner M; Thiede C; von Bonin M; Schetelig J; Kramer M; Berdel WE; Ehninger G;
Lancet Oncol; 2015 Dec; 16(16):1691-9. PubMed ID: 26549589
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of GABA
Chabriat H; Bassetti CL; Marx U; Audoli-Inthavong ML; Sors A; Lambert E; Wattez M; Hermann DM;
Lancet Neurol; 2020 Mar; 19(3):226-233. PubMed ID: 32085836
[TBL] [Abstract][Full Text] [Related]
32. Stem cell therapy for acute respiratory distress syndrome: a promising future?
Horie S; Masterson C; Devaney J; Laffey JG
Curr Opin Crit Care; 2016 Feb; 22(1):14-20. PubMed ID: 26645555
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of osilodrostat in patients with Cushing's disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase.
Pivonello R; Fleseriu M; Newell-Price J; Bertagna X; Findling J; Shimatsu A; Gu F; Auchus R; Leelawattana R; Lee EJ; Kim JH; Lacroix A; Laplanche A; O'Connell P; Tauchmanova L; Pedroncelli AM; Biller BMK;
Lancet Diabetes Endocrinol; 2020 Sep; 8(9):748-761. PubMed ID: 32730798
[TBL] [Abstract][Full Text] [Related]
34. A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial.
Villar J; Kacmarek RM; Pérez-Méndez L; Aguirre-Jaime A
Crit Care Med; 2006 May; 34(5):1311-8. PubMed ID: 16557151
[TBL] [Abstract][Full Text] [Related]
35. Bone Marrow-Derived Mesenchymal Stromal Cell Therapy in Severe COVID-19: Preliminary Results of a Phase I/II Clinical Trial.
Grégoire C; Layios N; Lambermont B; Lechanteur C; Briquet A; Bettonville V; Baudoux E; Thys M; Dardenne N; Misset B; Beguin Y
Front Immunol; 2022; 13():932360. PubMed ID: 35860245
[TBL] [Abstract][Full Text] [Related]
36. Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome: a randomized controlled trial.
Meade MO; Cook DJ; Guyatt GH; Slutsky AS; Arabi YM; Cooper DJ; Davies AR; Hand LE; Zhou Q; Thabane L; Austin P; Lapinsky S; Baxter A; Russell J; Skrobik Y; Ronco JJ; Stewart TE;
JAMA; 2008 Feb; 299(6):637-45. PubMed ID: 18270352
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of ABP 980 compared with reference trastuzumab in women with HER2-positive early breast cancer (LILAC study): a randomised, double-blind, phase 3 trial.
von Minckwitz G; Colleoni M; Kolberg HC; Morales S; Santi P; Tomasevic Z; Zhang N; Hanes V
Lancet Oncol; 2018 Jul; 19(7):987-998. PubMed ID: 29880292
[TBL] [Abstract][Full Text] [Related]
38. Ultra-low tidal volume ventilation for COVID-19-related ARDS in France (VT4COVID): a multicentre, open-label, parallel-group, randomised trial.
Richard JC; Terzi N; Yonis H; Chorfa F; Wallet F; Dupuis C; Argaud L; Delannoy B; Thiery G; Pommier C; Abraham P; Muller M; Sigaud F; Rigault G; Joffredo E; Mezidi M; Souweine B; Baboi L; Serrier H; Rabilloud M; Bitker L;
Lancet Respir Med; 2023 Nov; 11(11):991-1002. PubMed ID: 37453445
[TBL] [Abstract][Full Text] [Related]
39. [Effect of different transpulmonary pressures guided mechanical ventilation on respiratory and hemodynamics of patients with ARDS: a prospective randomized controlled trial].
Li J; Luo Z; Li X; Huang Z; Han J; Li Z; Zhou Z; Chen H
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):39-44. PubMed ID: 28459402
[TBL] [Abstract][Full Text] [Related]
40. Human placenta-derived mesenchymal stem cells transplantation in patients with acute respiratory distress syndrome (ARDS) caused by COVID-19 (phase I clinical trial): safety profile assessment.
Aghayan HR; Salimian F; Abedini A; Fattah Ghazi S; Yunesian M; Alavi-Moghadam S; Makarem J; Majidzadeh-A K; Hatamkhani A; Moghri M; Danesh A; Haddad-Marandi MR; Sanati H; Abbasvandi F; Arjmand B; Azimi P; Ghavamzadeh A; Sarrami-Forooshani R
Stem Cell Res Ther; 2022 Jul; 13(1):365. PubMed ID: 35902979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
